EUS & HPB RFA Focus Group

Breakfast Meeting At DDW 2016 San Diego


Date: Monday May 23rd, 2016

Time: 7:15am - 8:30am

Location: Marriott Marquis San Diego Marina, Torrey Pines Rooms


Join the EMcision team, including Professor Nagy Habib, along with specialist physicians for this focus group breakfast meeting on EUS and HPB RFA cases using the new Habib™ EUS RFA device and the Habib™ EndoHPB.

Click here to Register
To add this event to your calendar (click one): Google Calendar or iCal/Outlook

See additional DDW sessions and presentations featuring EMcision devices.





7:15am - Professor Nagy Habib: Speaker Introductions and Opening Remarks
7:25am - Dr. Mohamed Othman: EUS and Cysts
7:35am - Dr. Geoffrey Block: EUS and Neuroendocrine Tumors
7:45am - Dr. William Brugge: Study on RFA in Metal Stents
8:00am - Professor Bing Hu: Randomized Study RFA Cholangiocarcinoma
8:15am - Dr. Michel Kahaleh: Ablation in the Bile Ducts
8:25am - Professor Nagy Habib: Q&A, Closing Remarks


Presenters & Team


Professor Nagy Habib

Professor Habib is the Chairman and Medical Director of EMcision, as well as a leader and pioneer in Hepatobiliary Surgery. Based at Hammersmith Hospital in London, UK, Professor Habib is an award-winning and widely published researcher for novel therapies, techniques and devices - always innovating and pushing the envelope in his field.

Moderator and Host for this event.


Professor Bing Hu

Professor Bing Hu is the Chief and Director of Endoscopy, Chief and Director of the Department of Gastroenterology and a Professor of General Surgery at the Eastern Hepatobiliary Hospital and Second Military Medical University in Shanghai, China. He earned his M.D., M.M.S. and Ph.D in China, and was then a Research Fellow at Johns Hopkins University in Baltimore MD.

His main research interests include therapeutic and diagnostic endoscopy of the biliary tract and pancreas, endoscopic stenting, development of novel devices and techniques and laboratory study of biliary and pancreatic carcinoma.

Topic of discussion: Randomized prospective study on RFA in cholangiocarcinoma


Dr. Michel Kahaleh

Dr. Kahaleh is the chief of endoscopy at Weill Cornell Medical College. He is an expert in interventional endoscopy with special interest in ERCP, EUS and POEM. Trained in Erasme Hospital, University of Brussels, he led the Pancreato-Biliary team of endoscopists at the University of Virginia before joining the Weill Cornell Medical College in July 2011.

Topic of discussion: Ablation in the bile ducts


Dr. Mohamed Othman

Dr. Othman is the Director of Advanced Endoscopy and Assistant Professor of Medicine at Baylor College of Medicine. His clinical interests include endoscopic ultrasound evaluation of gastrointestinal malignancies and pancreatic cysts in addition to advanced techniques for tissue resections such as endoscopic mucosal resection and submucosal dissection of precancerous and cancerous lesions in the GI tract.

Dr. Othman earned his MD in Egypt. He completed a residency and gastroenterology fellowship at the University of New Mexico and then completed an advanced endoscopy fellowship at Mayo Clinic in Florida.

Topic of discussion: EUS & Cysts


Dr. Geoffrey Block

Dr. Block is the Director of Therapeutic Endoscopy at Eisenhower Medical Center, where he has established a program in interventional EUS, complex ERCP, ESD, and EMR in 2015. . He is Board Certified in Internal Medicine, Gastroenterology, and Transplant Hepatology. After receiving his MSc in Molecular Biology, Dr. Block completed his MD at Wake Forest University School of Medicine, and residencies, fellowships and post-docs at the University of Pittsburgh and UPMC.

He completed programs in Chronic Disease Epidemiology and Pediatric Endocrinology, Gastroenterology, Interventional Endoscopy, Hepatology, Transplant Medicine, Critical Care Medicine, and Aerospace Medicine, and continued as faculty at the University of Pittsburgh until moving to Eisenhower Medical Center in Southern California.

Topic of discussion: EUS & Neuroendocrine Tumors (NETs)


Dr. William Brugge

William R. Brugge, M.D. is the director of the Pancreas Biliary Center at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. He was previously the Director of Gastrointestinal Endoscopy also at Massachusetts General Hospital.

He completed his Doctor of Medicine with an Internal Medicine Residency Program at Baylor College of Medicine, and a Gastroenterology Fellowship at the University of Colorado Health Sciences Centre. Dr Brugge travelled to Europe and Japan to seek training on Endoscopic Ultrasound (EUS) and has since been pioneer of its use, particularly in the staging and diagnosis of pancreatic diseases. 

Topic of discussion: Study on RFA of Metal Stents


Event Registration

Please register your planned attendance to this event below.

Name *

Also Plan to Attend & Discover

ASGE 121: Endobiliary Radiofrequency Ablation Improves Overall Survival of Cholangiocarcinoma: A Multi-Center Randomized Control Study
Professor Bing Hu
Saturday May 21st 10:30am - 10:45am
Presentation during Topic Forum - Malignant Biliary Strictures: Can We Do Better? Are We Doing Too Much?
(See DDW Website for submitted abstract)

Sp211 Endo-biliary Ablation - RFA, PDT
Michel Kahaleh
Saturday May 21st 3:00 - 3:20pm
Presentation during Clinical Symposium - Endoscopic Therapy for Pacreaticobiliary Cancer

Sa2015: Endoscopic Radiofrequency Ablation for Intraductal Extension of Ampullary Neoplasms
Tarun Rustagi, Shayan Irani, Nageshwar D. Reddy, Barham K. Abu Dayyah, Todd H. Baron, Christopher Gostout, Michael J. Levy, John A. Martin, Bret T. Petersen, Andrew S. Ross and Mark Topazian.
Saturday May 21st
Poster during Main Session - ERCP New Technology

Mo2034: Evaluation of the Effects of Endoscopic Ultrasound Guided Radiofrequency Ablation of Ex-vivo Liver
Tarun Rustagi, Barham K. Abu Dayyeh, Ferga Gleeson, Mark Topazian and Michael J. Levy.
Monday May 23rd
Poster during Main Session - Endoscopy: New Therapeutic Technology

Tu1526: The Effect of Endoscopic Radiofrequency Ablation on Survival in Patients with Unresectable Peri-Hilar Cholangiocarcinoma
Kartik Sampath, Sarah M. Hyder, Timothy Gardner and Stuart R. Gordon.
Tuesday May 24th
Poster during Main Session - Endoscopy: ERCP Biliary Neoplasia